CCG-224406

N/A

Report date: 2023/03/21 14:11:32
NME

Base Information

Drug NameCCG-224406
Drug Alias NameCCG-224406
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-adrenergic receptor kinase 1 inhibitors
TargetsBeta-adrenergic receptor kinase 1
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTemple University
China Registration ClassN/A

Develop Information

Active CompaniesTemple University
Inactive CompaniesN/A
Active IndicationsHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A